Product Information
REPAGLINIDE 0.5 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0761 per EA under NDC 33342024811. Its NADAC has been published 73 times since Oct 16, 2024.
Strength
.5 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342024811
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
REPAGLINIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207209On Market Since
3/22/2023
Pharmacological Classes
Price Statistics
The NADAC for REPAGLINIDE 0.5 MG TABLET has been published 73 times since Oct 16, 2024, and over the history we have for it it has declined 25.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0761 per EA |
|---|---|
| All-time high | $0.1021 (Oct 16, 2024) |
| All-time low | $0.0723 (Dec 17, 2025) |
| 52-week high | $0.0890 |
| 52-week low | $0.0723 |
| Median price | $0.0796 |
| Average price | $0.0805 |
| Largest weekly change | -20.7% (Oct 23, 2024) |
| Weeks tracked | 73 |
| Tracking since | Oct 16, 2024 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of REPAGLINIDE 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for REPAGLINIDE 0.5 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.0761 per EA (NDC 33342024811), effective Jun 24, 2026.
How has the price of REPAGLINIDE 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for REPAGLINIDE 0.5 MG TABLET has declined 25.5%. It has been tracked across 73 weekly CMS publications since Oct 16, 2024.
What are the highest and lowest recorded NADAC prices for REPAGLINIDE 0.5 MG TABLET?
Since Oct 16, 2024, the NADAC for REPAGLINIDE 0.5 MG TABLET has ranged from a low of $0.0723 (Dec 17, 2025) to a high of $0.1021 (Oct 16, 2024), with a median of $0.0796 per EA.
Are there cheaper alternatives to REPAGLINIDE 0.5 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as REPAGLINIDE 0.5 MG TABLET, but none are currently priced below it.
Who manufactures REPAGLINIDE 0.5 MG TABLET?
REPAGLINIDE 0.5 MG TABLET (NDC 33342024811) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification